Ulcerative Colitis and the Role of S1P Receptor Modulators and JAK Inhibitors " A Wheel of Knowledge Challenge!

Ulcerative colitis (UC), a type of inflammatory bowel disease, is a chronic relapsing condition characterized by an overly active immune response in the large intestine, resulting in inflammation and ulceration. Given the increasing prevalence of disease and rapid influx of available biologics and small molecule therapies, there is great need for ongoing education regarding new and emerging treatment approaches for the management of UC. In this continuing education program, expert clinicians will discuss the role of sphingosine-1-phosphate (S1P) and Janus kinase (JAK) signaling in the pathophysiology and treatment of UC. Faculty will evaluate the safety and efficacy of current and emerging therapies and discuss optimal positioning of S1P receptor modulators and JAK inhibitors in the shifting UC treatment paradigm. This program will include case-based discussion and the unique, audience-engaging educational gaming platform, A Wheel of Knowledge Challenge.